Author: Alessandra Maleddu, MD – University of Colorado Anschutz Medical Campus
### @@@ Kenneth Cardona, MD, FACS – Winship Cancer Institute, Emory University ### 1094306###Co-Author###Surgical Oncologist###Winship Cancer Institute, Emory University###Co-Author: Kenneth Cardona, MD, FACS – Winship Cancer Institute, Emory University
### @@@ Breelyn A. Wilky, MD (she/her/hers) – University of Colorado ### 1429940###Co-Author###Associate Professor | Director, Sarcoma Medical Oncology###University of Colorado###Co-Author: Breelyn A. Wilky, MD (she/her/hers) – University of Colorado
### she/her/hers @@@ Andrea P. Espejo Freire, MD (she/her/hers) – University of Miami ### 1768891###Co-Author###Hematology Oncology Fellow###University of Miami###Co-Author: Andrea P. Espejo Freire, MD (she/her/hers) – University of Miami
### she/her/hers @@@ Steve Bandula, MD PhD MRCS FRCR – University College Hospital London NHS Foundation Trust ### 1768893###Co-Author######University College Hospital London NHS Foundation Trust###Co-Author: Steve Bandula, MD PhD MRCS FRCR – University College Hospital London NHS Foundation Trust
### @@@ Analie Morales, CNS – University College London Hospital NHS Foundation Trust ### 1768894###Co-Author######University College London Hospital NHS Foundation Trust###Co-Author: Analie Morales, CNS – University College London Hospital NHS Foundation Trust
### @@@ Eve Merry – University College London Hospital NHS Foundation Trust ### 1768902###Co-Author###Medical Oncology Specialist Registrar ###University College London Hospital NHS Foundation Trust###Co-Author: Eve Merry – University College London Hospital NHS Foundation Trust
### @@@ Mesel Veli, MD – University College Hospital London NHS Foundation Trust ### 1768892###Co-Author###Medical Oncology Registrar###University College Hospital London NHS Foundation Trust###Co-Author: Mesel Veli, MD – University College Hospital London NHS Foundation Trust
### @@@ Jessica M. Keilson, MD – Division of Surgical Oncology, Winship Cancer Institute, Emory University Hospital ### 1768895###Co-Author###Clinical Research Fellow###Division of Surgical Oncology, Winship Cancer Institute, Emory University Hospital###Co-Author: Jessica M. Keilson, MD – Division of Surgical Oncology, Winship Cancer Institute, Emory University Hospital
### @@@ Melinda Yushak, MD – Division of Surgical Oncology, Winship Cancer Institute, Emory University Hospital ### 1768896###Co-Author######Division of Surgical Oncology, Winship Cancer Institute, Emory University Hospital###Co-Author: Melinda Yushak, MD – Division of Surgical Oncology, Winship Cancer Institute, Emory University Hospital
### @@@ David J Prologo, MD – Division of Surgical Oncology, Winship Cancer Institute, Emory University Hospital ### 1768898###Co-Author######Division of Surgical Oncology, Winship Cancer Institute, Emory University Hospital###Co-Author: David J Prologo, MD – Division of Surgical Oncology, Winship Cancer Institute, Emory University Hospital
### @@@ David C. Gimarc, MD – Department of Radiology, University of Colorado School of Medicine - Anschutz Medical Campus ### 1768900###Co-Author###Assistant Professor of Radiology###Department of Radiology, University of Colorado School of Medicine - Anschutz Medical Campus###Co-Author: David C. Gimarc, MD – Department of Radiology, University of Colorado School of Medicine - Anschutz Medical Campus
### @@@ Mary J Underdown, MD – Department of Radiology, University of Colorado School of Medicine - Anschutz Medical Campus ### 1768901###Co-Author######Department of Radiology, University of Colorado School of Medicine - Anschutz Medical Campus###Co-Author: Mary J Underdown, MD – Department of Radiology, University of Colorado School of Medicine - Anschutz Medical Campus
### @@@ Shree Venkat, MD (she/her/hers) – University of Miami/Sylvester Comprehensive Cancer Center ### 1768874###Co-Author###Asst Professor Interventional Radiology###University of Miami/Sylvester Comprehensive Cancer Center###Co-Author: Shree Venkat, MD (she/her/hers) – University of Miami/Sylvester Comprehensive Cancer Center
### she/her/hers @@@ Emily Jonczak, MD (she/her/hers) – University of Miami/Sylvester Comprehensive Cancer Center ### 1768841###Co-Author###Assistant Professor; Division of Oncology; Sarcoma ###University of Miami/Sylvester Comprehensive Cancer Center###Co-Author: Emily Jonczak, MD (she/her/hers) – University of Miami/Sylvester Comprehensive Cancer Center
### she/her/hers @@@ Gina D'Amato, MD – University of Miami/Sylvester Comprehensive Cancer Center ### 1429573###Co-Author###Associate Professor of Medicine/Sarcoma Medical Oncology###University of Miami/Sylvester Comprehensive Cancer Center###Co-Author: Gina D'Amato, MD – University of Miami/Sylvester Comprehensive Cancer Center
### @@@ Palma Dileo, MD – University College London Hospitals NHS Foundation Trust ### 1138277###Co-Author###Consultant Medical Oncologist ###University College London Hospitals NHS Foundation Trust###Co-Author: Palma Dileo, MD – University College London Hospitals NHS Foundation Trust
### Paper 78Author: Siddh van Oost, MSc – Department of Pathology / Leiden Centre for Computational Oncology, Leiden University Medical Center
### @@@ Debora Meijer, MSc – Department of Pathology / Leiden Centre for Computational Oncology, Leiden University Medical Center ### 1768961###Co-Author###PhD Candidate###Department of Pathology / Leiden Centre for Computational Oncology, Leiden University Medical Center###Co-Author: Debora Meijer, MSc – Department of Pathology / Leiden Centre for Computational Oncology, Leiden University Medical Center
### @@@ Brendy E. van Den Akker, N/A, BSc – LUMC ### 1430561###Co-Author######LUMC###Co-Author: Brendy E. van Den Akker, N/A, BSc – LUMC
### @@@ Ruud Van Der Breggen, BSc – Department of Pathology, LUMC ### 1768962###Co-Author######Department of Pathology, LUMC###Co-Author: Ruud Van Der Breggen, BSc – Department of Pathology, LUMC
### @@@ Inge H. Braire-deBruijn, N/A, MD – Department of Pathology, Leiden University Medical Center, Leiden ### 1430562###Co-Author######Department of Pathology, Leiden University Medical Center, Leiden###Co-Author: Inge H. Braire-deBruijn, N/A, MD – Department of Pathology, Leiden University Medical Center, Leiden
### @@@ Marieke Ijsselsteijn, MSc – Department of Pathology, LUMC ### 1768963###Co-Author######Department of Pathology, LUMC###Co-Author: Marieke Ijsselsteijn, MSc – Department of Pathology, LUMC
### @@@ Wilco Peul, Professor, MD – University Neurosurgical Centre Holland, LUMC ### 1768965###Co-Author######University Neurosurgical Centre Holland, LUMC###Co-Author: Wilco Peul, Professor, MD – University Neurosurgical Centre Holland, LUMC
### @@@ Robert Van der Wal, MD, PhD (he/him/his) – Leiden University Medical center ### 1768890###Co-Author###Department of Orthopedics###Leiden University Medical center###Co-Author: Robert Van der Wal, MD, PhD (he/him/his) – Leiden University Medical center
### he/him/his @@@ Manon van der ploeg, BSc – Department of Pathology, LUMC ### 1768966###Co-Author######Department of Pathology, LUMC###Co-Author: Manon van der ploeg, BSc – Department of Pathology, LUMC
### @@@ Samuel Polak, MD – University Neurosurgical Centre Holland, LUMC ### 1768967###Co-Author######University Neurosurgical Centre Holland, LUMC###Co-Author: Samuel Polak, MD – University Neurosurgical Centre Holland, LUMC
### @@@ Jessica Roelands, PhD – Department of Pathology, LUMC ### 1768970###Co-Author######Department of Pathology, LUMC###Co-Author: Jessica Roelands, PhD – Department of Pathology, LUMC
### @@@ Pauline Wijers-Koster, BSc – Department of Pathology, LUMC ### 1431331###Co-Author######Department of Pathology, LUMC###Co-Author: Pauline Wijers-Koster, BSc – Department of Pathology, LUMC
### @@@ Noel de Miranda, PhD – Department of Pathology / Leiden Centre for Computational Oncology, Leiden University Medical Center ### 1768973###Co-Author###Associate Professor###Department of Pathology / Leiden Centre for Computational Oncology, Leiden University Medical Center###Co-Author: Noel de Miranda, PhD – Department of Pathology / Leiden Centre for Computational Oncology, Leiden University Medical Center
### @@@ J.V.M.G. Bovee, MD, PhD – Department of Pathology, Leiden University Medical Center ### 1137174###Co-Author###Prof. Dr.###Department of Pathology, Leiden University Medical Center###Co-Author: J.V.M.G. Bovee, MD, PhD – Department of Pathology, Leiden University Medical Center
### Paper 54Author: Eugenie S. Kleinerman, MD (she/her/hers) – MD Anderson Cancer Center
### she/her/hers @@@ Yuanzheng Yang, PhD – MD Anderson Cancer Center ### 1768783###Co-Author###Research Scientist###MD Anderson Cancer Center###Co-Author: Yuanzheng Yang, PhD – MD Anderson Cancer Center
### @@@ Yifan Zhou, PhD – MD Anderson Cancer Center ### 1768787###Co-Author######MD Anderson Cancer Center###Co-Author: Yifan Zhou, PhD – MD Anderson Cancer Center
### @@@ Stepahnie Watowich, PhD – MD Anderson Cancer Center ### 1768788###Co-Author###Professor###MD Anderson Cancer Center###Co-Author: Stepahnie Watowich, PhD – MD Anderson Cancer Center
### Paper 88Author: Andrea Napolitano, MD, PhD (he/him/his) – The Royal Marsden NHS Foundation Trust
### he/him/his @@@ Sebastian Bauer, MD (he/him/his) – Department of Medical Oncology, Sarcoma Center, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen and German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany ### 1429571###Co-Author###Director Sarcoma Center###Department of Medical Oncology, Sarcoma Center, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen and German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany###Co-Author: Sebastian Bauer, MD (he/him/his) – Department of Medical Oncology, Sarcoma Center, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen and German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany
### he/him/his @@@ Piotr Rutkowski, MD, PhD – Department of Soft Tissue/Bone Sarcoma and Melanoma; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland ### 1136448###Co-Author###Head of Department of Soft Tissue/Bone Sarcoma and Melanoma, Professor of Surgical Oncology###Department of Soft Tissue/Bone Sarcoma and Melanoma; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland###Co-Author: Piotr Rutkowski, MD, PhD – Department of Soft Tissue/Bone Sarcoma and Melanoma; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
### @@@ Jean-Yves Blay, MD, PhD (he/him/his) – Centre Léon Bérard and Université Claude Bernard, Lyon, France ### 1136458###Co-Author###Professor of Medicine,###Centre Léon Bérard and Université Claude Bernard, Lyon, France###Co-Author: Jean-Yves Blay, MD, PhD (he/him/his) – Centre Léon Bérard and Université Claude Bernard, Lyon, France
### he/him/his @@@ Peter Reichardt, MD, PhD (he/him/his) – Helios Klinikum Berlin-Buch ### 1429575###Co-Author###Head, Department of Oncology and Palliative Care###Helios Klinikum Berlin-Buch###Co-Author: Peter Reichardt, MD, PhD (he/him/his) – Helios Klinikum Berlin-Buch
### he/him/his @@@ Heikki Joensuu, N/A, MD, PhD – Helsinki University Central Hospital and University of Helsinki ### 1475968###Co-Author######Helsinki University Central Hospital and University of Helsinki###Co-Author: Heikki Joensuu, N/A, MD, PhD – Helsinki University Central Hospital and University of Helsinki
### @@@ Arun S. Singh, MD – University of California at Los Angeles ### 1430362###Co-Author###Associate Professor###University of California at Los Angeles###Co-Author: Arun S. Singh, MD – University of California at Los Angeles
### @@@ Michael C. Heinrich, MD – Oregon Health and Science University ### 1431071###Co-Author###Professor of Medicine###Oregon Health and Science University###Co-Author: Michael C. Heinrich, MD – Oregon Health and Science University
### @@@ Thomas Sutton, MD (he/him/his) – Oregon Health and Science University ### 1768645###Co-Author###Resident###Oregon Health and Science University###Co-Author: Thomas Sutton, MD (he/him/his) – Oregon Health and Science University
### he/him/his @@@ Denisse Montoya, MSc (she/her/hers) – The Life Raft Group ### 1768646###Co-Author###Senior Director, Data Management and Research ###The Life Raft Group###Co-Author: Denisse Montoya, MSc (she/her/hers) – The Life Raft Group
### she/her/hers @@@ Elena R. Fumagalli, N/A, MD – Istituto Nazionale Tumori ### 1431509###Co-Author######Istituto Nazionale Tumori###Co-Author: Elena R. Fumagalli, N/A, MD – Istituto Nazionale Tumori
### @@@ Antoine Italiano, N/A, MD, PhD – Institut Bergonié ### 1429672###Co-Author######Institut Bergonié###Co-Author: Antoine Italiano, N/A, MD, PhD – Institut Bergonié
### @@@ Giovanni Grignani, MD – Department of Medical Oncology-Sarcoma Unit, Candiolo Cancer Institute FPO-IRCCS, Candiolo (TO), Italy ### 1136395###Co-Author###Medical Oncologist###Department of Medical Oncology-Sarcoma Unit, Candiolo Cancer Institute FPO-IRCCS, Candiolo (TO), Italy###Co-Author: Giovanni Grignani, MD – Department of Medical Oncology-Sarcoma Unit, Candiolo Cancer Institute FPO-IRCCS, Candiolo (TO), Italy
### @@@ Antonella Brunello, MD PhD (she/her/hers) – Veneto Institute of Oncology IOV – IRCCS ### 1430043###Co-Author###Medical Oncologist###Veneto Institute of Oncology IOV – IRCCS###Co-Author: Antonella Brunello, MD PhD (she/her/hers) – Veneto Institute of Oncology IOV – IRCCS
### she/her/hers @@@ Maria A. Pantaleo, N/A, MD – DIMES ### 1136436###Co-Author###Associate Professor###DIMES###Co-Author: Maria A. Pantaleo, N/A, MD – DIMES
### @@@ Winan J. Van Houdt, MSc, MD, PhD – The Netherlands Cancer Institute ### 1138278###Co-Author###Surgical Oncologist###The Netherlands Cancer Institute###Co-Author: Winan J. Van Houdt, MSc, MD, PhD – The Netherlands Cancer Institute
### @@@ Nikki IJzerman, MD – Netherlands Cancer Institute and Erasmus MC Cancer Institute ### 1136456###Co-Author###PhD Student###Netherlands Cancer Institute and Erasmus MC Cancer Institute###Co-Author: Nikki IJzerman, MD – Netherlands Cancer Institute and Erasmus MC Cancer Institute
### @@@ Neeltje Steeghs, N/A, MD – The Netherlands Cancer Institute ### 1429763###Co-Author######The Netherlands Cancer Institute###Co-Author: Neeltje Steeghs, N/A, MD – The Netherlands Cancer Institute
### @@@ Hans Gelderblom, MD, PhD – Leiden University Medical Center, Leiden, Netherlands ### 1094423###Co-Author###Professor medical oncology###Leiden University Medical Center, Leiden, Netherlands###Co-Author: Hans Gelderblom, MD, PhD – Leiden University Medical Center, Leiden, Netherlands
### @@@ Ingrid Desar, N/A, MD – Radboud University Medical Centre ### 1431114###Co-Author###Medical oncologist###Radboud University Medical Centre###Co-Author: Ingrid Desar, N/A, MD – Radboud University Medical Centre
### @@@ Javier Martín-Broto, MD, PhD – Fundacíon Jiménez Díaz University Hospital, ATBSARC lab in General Hospital of Villalba, IIS-FJD, Madrid, Spain ### 1429624###Co-Author###Medical Oncologist###Fundacíon Jiménez Díaz University Hospital, ATBSARC lab in General Hospital of Villalba, IIS-FJD, Madrid, Spain###Co-Author: Javier Martín-Broto, MD, PhD – Fundacíon Jiménez Díaz University Hospital, ATBSARC lab in General Hospital of Villalba, IIS-FJD, Madrid, Spain
### @@@ Peter Hohenberger, N/A, MD – University Hospital Essen ### 1431200###Co-Author######University Hospital Essen###Co-Author: Peter Hohenberger, N/A, MD – University Hospital Essen
### @@@ Axel Le Cesne, MD – Department of Medicine, Gustave Roussy ### 1429670###Co-Author######Department of Medicine, Gustave Roussy###Co-Author: Axel Le Cesne, MD – Department of Medicine, Gustave Roussy
### @@@ Robin L. Jones, N/A, MD, PhD – The Royal Marsden NHS Foundation Trust ### 1430162###Co-Author######The Royal Marsden NHS Foundation Trust###Co-Author: Robin L. Jones, N/A, MD, PhD – The Royal Marsden NHS Foundation Trust
### @@@ Angelo Dei Tos, N/A, MD, PhD – Azienda Ospedaliera di Padova ### 1136417###Co-Author######Azienda Ospedaliera di Padova###Co-Author: Angelo Dei Tos, N/A, MD, PhD – Azienda Ospedaliera di Padova
### @@@ Alessandro Gronchi, MD, FSSO (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori ### 1136460###Co-Author###Surgical Oncologist###Fondazione IRCCS Istituto Nazionale dei Tumori###Co-Author: Alessandro Gronchi, MD, FSSO (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori
### he/him/his @@@ Robert G. Maki, MD, PhD – Abramson Cancer Center ### 1768566###Co-Author######Abramson Cancer Center###Co-Author: Robert G. Maki, MD, PhD – Abramson Cancer Center
### @@@ Jonathan C. Trent, MD, PhD – University of Miami/Sylvester Comprehensive Cancer Center ### 1094343###Co-Author###Professor and Associate Director for Clinical Research###University of Miami/Sylvester Comprehensive Cancer Center###Co-Author: Jonathan C. Trent, MD, PhD – University of Miami/Sylvester Comprehensive Cancer Center
### @@@ Paolo G. Casali, MD – University of Milan ### 1136447###Co-Author###Associate Professor in Medical Oncology###University of Milan###Co-Author: Paolo G. Casali, MD – University of Milan
### @@@ Bruno Vincenzi, Medical Oncologist, MD, PhD – Campus Bio-Medico University of Rome ### 1768647###Co-Author###Full professor###Campus Bio-Medico University of Rome###Co-Author: Bruno Vincenzi, Medical Oncologist, MD, PhD – Campus Bio-Medico University of Rome
### Paper 43Author: Brian A. Van Tine, MD, PhD – Washington University School of Medicine
### @@@ Matthew A. Ingham, MD – New York Presbyterian Hospital/Columbia University Medical Center ### 1429590###Co-Author###Assistant Professor of Medicine Division of Hematology and Oncology###New York Presbyterian Hospital/Columbia University Medical Center###Co-Author: Matthew A. Ingham, MD – New York Presbyterian Hospital/Columbia University Medical Center
### @@@ Steven Attia, D.O. – Mayo Clinic ### 1429572###Co-Author###Consultant ###Mayo Clinic###Co-Author: Steven Attia, D.O. – Mayo Clinic
### @@@ Christian F. Meyer, MD, PhD – Johns Hopkins Sidney Kimmel Cancer Center ### 1431376###Co-Author###Assistant Professor of Oncology###Johns Hopkins Sidney Kimmel Cancer Center###Co-Author: Christian F. Meyer, MD, PhD – Johns Hopkins Sidney Kimmel Cancer Center
### @@@ John D. Baird, PhD (he/him/his) – PTC Therapeutics, Inc. ### 1769002###Co-Author###CoS###PTC Therapeutics, Inc.###Co-Author: John D. Baird, PhD (he/him/his) – PTC Therapeutics, Inc.
### he/him/his @@@ Dhiren D'Silva, MBA (he/him/his) – PTC Therapeutics, Inc. ### 1769003###Co-Author###VP Commercial Excellence###PTC Therapeutics, Inc.###Co-Author: Dhiren D'Silva, MBA (he/him/his) – PTC Therapeutics, Inc.
### he/him/his @@@ Kylie O’Keefe, n/a – PTC Therapeutics, Inc. ### 1769004###Co-Author######PTC Therapeutics, Inc.###Co-Author: Kylie O’Keefe, n/a – PTC Therapeutics, Inc.
### @@@ Pius P. Maliakal, MS, PhD – PTC Therapeutics, Inc. ### 1769005###Co-Author######PTC Therapeutics, Inc.###Co-Author: Pius P. Maliakal, MS, PhD – PTC Therapeutics, Inc.
### @@@ Mona Wahba, MD, MSM – PTC Therapeutics, Inc. ### 1769006###Co-Author######PTC Therapeutics, Inc.###Co-Author: Mona Wahba, MD, MSM – PTC Therapeutics, Inc.
### @@@ Marla Weetall, PhD – PTC Therapeutics, Inc. ### 1769007###Co-Author######PTC Therapeutics, Inc.###Co-Author: Marla Weetall, PhD – PTC Therapeutics, Inc.
### @@@ Gary K. Schwartz, MD – Columbia University Herbert Irving Comprehensive Cancer Center ### 1768569###Co-Author###Professor of Medicine###Columbia University Herbert Irving Comprehensive Cancer Center###Co-Author: Gary K. Schwartz, MD – Columbia University Herbert Irving Comprehensive Cancer Center
### Paper 17Author: Breelyn A. Wilky, MD (she/her/hers) – University of Colorado
### she/her/hers @@@ Justin C. Moser, N/A, MD – HonorHealth Research and Innovation Institute ### 1769487###Co-Author###Associate Clinical Investigator, Melanoma and Cutaneous Oncology Specialist###HonorHealth Research and Innovation Institute###Co-Author: Justin C. Moser, N/A, MD – HonorHealth Research and Innovation Institute
### @@@ Michael S. Gordon, MD (he/him/his) – HonorHealth Research Institute ### 1769488###Co-Author###Chief Medical Officer###HonorHealth Research Institute###Co-Author: Michael S. Gordon, MD (he/him/his) – HonorHealth Research Institute
### he/him/his @@@ Leah Anton, N/A, NP, MSN – Sylvester Comprehensive Cancer Center, University of Miami ### 1769489###Co-Author###Research Oncology Nurse Practitioner Fellow###Sylvester Comprehensive Cancer Center, University of Miami###Co-Author: Leah Anton, N/A, NP, MSN – Sylvester Comprehensive Cancer Center, University of Miami
### @@@ Marwan G. Fakih, N/A, MD – City of Hope Comprehensive Cancer Center ### 1769490###Co-Author###Associate Director for Clinical Sciences###City of Hope Comprehensive Cancer Center###Co-Author: Marwan G. Fakih, N/A, MD – City of Hope Comprehensive Cancer Center
### @@@ Mark Agulnik, MD – City of Hope Comprehensive Cancer Center ### 1430039###Co-Author###Clinical Professor###City of Hope Comprehensive Cancer Center###Co-Author: Mark Agulnik, MD – City of Hope Comprehensive Cancer Center
### @@@ Andrea Bullock, N/A, MD – Beth Israel Deaconess Medical Center ### 1769491###Co-Author###Assistant Professor in Medicine, Harvard Medical School###Beth Israel Deaconess Medical Center###Co-Author: Andrea Bullock, N/A, MD – Beth Israel Deaconess Medical Center
### @@@ J. Luke Godwin, N/A, MD – Agenus ### 1769492###Co-Author###Vice President, Late Stage Clinical Development###Agenus###Co-Author: J. Luke Godwin, N/A, MD – Agenus
### @@@ Jaymin M. Patel, MD ### 1776671###Co-Author###Executive Medical Director, Head of Biomarkers######Co-Author: Jaymin M. Patel, MD
### @@@ Joseph E. Grossman, N/A, MD – Agenus ### 1769493###Co-Author###Vice President, Head of Exploratory Medicine###Agenus###Co-Author: Joseph E. Grossman, N/A, MD – Agenus
### @@@ Waldo Ortuzar Feliu, N/A, MD – Agenus ### 1769494###Co-Author###Senior Medical Director###Agenus###Co-Author: Waldo Ortuzar Feliu, N/A, MD – Agenus
### @@@ Katherine Rosenthal, RN, MSN, OCN, CCRP (she/her/hers) – Agenus ### 1769495###Co-Author###Director, Clinical Program Management###Agenus###Co-Author: Katherine Rosenthal, RN, MSN, OCN, CCRP (she/her/hers) – Agenus
### she/her/hers @@@ Bhupendra Rawal, N/A, MS – Agenus ### 1769496###Co-Author###Associate Director of Biostatistics###Agenus###Co-Author: Bhupendra Rawal, N/A, MS – Agenus
### @@@ Bonnie L. Bullock, PhD (she/her/hers) – Agenus ### 1769486###Co-Author###Senior Scientific Writer, Publications###Agenus###Co-Author: Bonnie L. Bullock, PhD (she/her/hers) – Agenus
### she/her/hers @@@ Hunter Cole, N/A, MPH – Agenus ### 1769497###Co-Author###Project Manager###Agenus###Co-Author: Hunter Cole, N/A, MPH – Agenus
### @@@ Steven J. O'Day, MD (he/him/his) – Agenus ### 1769498###Co-Author###Chief Medical Officer###Agenus###Co-Author: Steven J. O'Day, MD (he/him/his) – Agenus
### he/him/his @@@ Anthony B. El-Khoueiry, N/A, MD – University of Southern California Norris Comprehensive Cancer Center ### 1431373###Co-Author###Associate Professor of Medicine###University of Southern California Norris Comprehensive Cancer Center###Co-Author: Anthony B. El-Khoueiry, N/A, MD – University of Southern California Norris Comprehensive Cancer Center
### @@@ Gary K. Schwartz, MD – Columbia University Herbert Irving Comprehensive Cancer Center ### 1768569###Co-Author###Professor of Medicine###Columbia University Herbert Irving Comprehensive Cancer Center###Co-Author: Gary K. Schwartz, MD – Columbia University Herbert Irving Comprehensive Cancer Center
### @@@ Apostolia M. Tsimberidou, N/A, MD, PhD – The University of Texas MD Anderson Cancer Center ### 1769499###Co-Author###Tenured Professor and Principal Investigator###The University of Texas MD Anderson Cancer Center###Co-Author: Apostolia M. Tsimberidou, N/A, MD, PhD – The University of Texas MD Anderson Cancer Center
### @@@ Jonathan C. Trent, MD, PhD – University of Miami/Sylvester Comprehensive Cancer Center ### 1094343###Co-Author###Professor and Associate Director for Clinical Research###University of Miami/Sylvester Comprehensive Cancer Center###Co-Author: Jonathan C. Trent, MD, PhD – University of Miami/Sylvester Comprehensive Cancer Center
### Paper 58Author: Mrinal M. Gounder, MD – Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center
### @@@ Patrick Schöffski, MD, MPH – Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute ### 1094293###Co-Author###Head Department of General Medical Oncology###Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute###Co-Author: Patrick Schöffski, MD, MPH – Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute
### @@@ Noboru Yamamoto, N/A, MD, PhD – Department of Experimental Therapeutics, National Cancer Center Hospital ### 1431161###Co-Author######Department of Experimental Therapeutics, National Cancer Center Hospital###Co-Author: Noboru Yamamoto, N/A, MD, PhD – Department of Experimental Therapeutics, National Cancer Center Hospital
### @@@ Todd M. Bauer, N/A, MD – Sarah Cannon Research Institute, Tennessee Oncology ### 1431162###Co-Author######Sarah Cannon Research Institute, Tennessee Oncology###Co-Author: Todd M. Bauer, N/A, MD – Sarah Cannon Research Institute, Tennessee Oncology
### @@@ Manish R. Patel, N/A, MD – Sarah Cannon Research Institute, Florida Cancer Specialists & Research Institute ### 1431160###Co-Author######Sarah Cannon Research Institute, Florida Cancer Specialists & Research Institute###Co-Author: Manish R. Patel, N/A, MD – Sarah Cannon Research Institute, Florida Cancer Specialists & Research Institute
### @@@ Junxian Geng, PhD – Boehringer Ingelheim Pharmaceuticals, Inc. ### 1431165###Co-Author###Principal Clinical Data Scientist###Boehringer Ingelheim Pharmaceuticals, Inc.###Co-Author: Junxian Geng, PhD – Boehringer Ingelheim Pharmaceuticals, Inc.
### @@@ Sara Durland-Busbice, N/A, n/a – Boehringer Ingelheim Pharmaceuticals Inc ### 1768667###Co-Author######Boehringer Ingelheim Pharmaceuticals Inc###Co-Author: Sara Durland-Busbice, N/A, n/a – Boehringer Ingelheim Pharmaceuticals Inc
### @@@ Michael Teufel, PhD (he/him/his) – Boehringer Ingelheim Pharmaceuticals, Inc. ### 1768666###Co-Author###Executive Director###Boehringer Ingelheim Pharmaceuticals, Inc.###Co-Author: Michael Teufel, PhD (he/him/his) – Boehringer Ingelheim Pharmaceuticals, Inc.
### he/him/his @@@ Girish Jayadeva, N/A, MBBS, PhD – Boehringer Ingelheim International GmbH ### 1768668###Co-Author######Boehringer Ingelheim International GmbH###Co-Author: Girish Jayadeva, N/A, MBBS, PhD – Boehringer Ingelheim International GmbH
### @@@ Patricia LoRusso, N/A, PhD – Yale University School of Medicine, Yale Cancer Center ### 1431168###Co-Author######Yale University School of Medicine, Yale Cancer Center###Co-Author: Patricia LoRusso, N/A, PhD – Yale University School of Medicine, Yale Cancer Center
### Paper 19Author: Chiara Colombo, N/A, MD – Fondazione IRCCS Istituto Nazionale dei Tumori
### @@@ Anne-Rose W. Schut, MD (she/her/hers) – Erasmus Medical Center Rotterdam ### 1430724###Presenter###PhD Candidate###Erasmus Medical Center Rotterdam###Presenter: Anne-Rose W. Schut, MD (she/her/hers) – Erasmus Medical Center Rotterdam
### she/her/hers @@@ Francesco Barretta, PhD (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori ### 1431109###Co-Author###Health researcher###Fondazione IRCCS Istituto Nazionale dei Tumori###Co-Author: Francesco Barretta, PhD (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori
### he/him/his @@@ Dirk J. Grünhagen, N/A, MD, PhD – Erasmus Medical Center ### 1430415###Co-Author###Associate Professor Surgical Oncology###Erasmus Medical Center###Co-Author: Dirk J. Grünhagen, N/A, MD, PhD – Erasmus Medical Center
### @@@ Marco Fiore, MD, FACS, FEBS – Fondazione IRCCS Istituto Nazionale dei Tumori ### 1094302###Co-Author###Surgical Oncologist###Fondazione IRCCS Istituto Nazionale dei Tumori###Co-Author: Marco Fiore, MD, FACS, FEBS – Fondazione IRCCS Istituto Nazionale dei Tumori
### @@@ Milea J.M. Timbergen, MD, PhD – Erasmus Medical Center Rotterdam ### 1430725###Co-Author######Erasmus Medical Center Rotterdam###Co-Author: Milea J.M. Timbergen, MD, PhD – Erasmus Medical Center Rotterdam
### @@@ Elena Palassini, N/A, MD – Fondazione IRCCS Istituto Nazionale dei Tumori ### 1431515###Co-Author######Fondazione IRCCS Istituto Nazionale dei Tumori###Co-Author: Elena Palassini, N/A, MD – Fondazione IRCCS Istituto Nazionale dei Tumori
### @@@ Danique L.M. van Broekhoven, MD, PhD – Erasmus Medical Center Rotterdam ### 1431474###Co-Author######Erasmus Medical Center Rotterdam###Co-Author: Danique L.M. van Broekhoven, MD, PhD – Erasmus Medical Center Rotterdam
### @@@ Giovanni Grignani, MD – Department of Medical Oncology-Sarcoma Unit, Candiolo Cancer Institute FPO-IRCCS, Candiolo (TO), Italy ### 1136395###Co-Author###Medical Oncologist###Department of Medical Oncology-Sarcoma Unit, Candiolo Cancer Institute FPO-IRCCS, Candiolo (TO), Italy###Co-Author: Giovanni Grignani, MD – Department of Medical Oncology-Sarcoma Unit, Candiolo Cancer Institute FPO-IRCCS, Candiolo (TO), Italy
### @@@ Thijs van Dalen, MD, PhD – University Medical Center Utrecht ### 1768881###Co-Author######University Medical Center Utrecht###Co-Author: Thijs van Dalen, MD, PhD – University Medical Center Utrecht
### @@@ Francesco Tolomeo, MD – Candiolo Cancer Institute FPO-IRCCS, Candiolo (TO), Italy ### 1431264###Co-Author######Candiolo Cancer Institute FPO-IRCCS, Candiolo (TO), Italy###Co-Author: Francesco Tolomeo, MD – Candiolo Cancer Institute FPO-IRCCS, Candiolo (TO), Italy
### @@@ Winan J. Van Houdt, MSc, MD, PhD – The Netherlands Cancer Institute ### 1138278###Co-Author###Surgical Oncologist###The Netherlands Cancer Institute###Co-Author: Winan J. Van Houdt, MSc, MD, PhD – The Netherlands Cancer Institute
### @@@ Paola Collini, MD – Fondazione IRCCS Istituto Nazionale dei Tumori ### 1430011###Co-Author###Pathologist###Fondazione IRCCS Istituto Nazionale dei Tumori###Co-Author: Paola Collini, MD – Fondazione IRCCS Istituto Nazionale dei Tumori
### @@@ Han Bonenkamp, MSc, MD, PhD (he/him/his) – Radboud University Medical Center ### 1431035###Co-Author###Surgical Oncologist###Radboud University Medical Center###Co-Author: Han Bonenkamp, MSc, MD, PhD (he/him/his) – Radboud University Medical Center
### he/him/his @@@ Alessandra Merlini, MD – Department of Oncology, University of Turin ### 1768882###Co-Author###Research Fellow###Department of Oncology, University of Turin###Co-Author: Alessandra Merlini, MD – Department of Oncology, University of Turin
### @@@ Stefan Sleijfer, MD, PhD – Erasmus Medical Center Rotterdam ### 1430726###Co-Author######Erasmus Medical Center Rotterdam###Co-Author: Stefan Sleijfer, MD, PhD – Erasmus Medical Center Rotterdam
### @@@ Frits van Coevorden, MD, PhD (he/him/his) – The Netherlands Cancer Institute ### 1430899###Co-Author###Retired###The Netherlands Cancer Institute###Co-Author: Frits van Coevorden, MD, PhD (he/him/his) – The Netherlands Cancer Institute
### he/him/his @@@ Federica Perrone, MD – Fondazione IRCCS Istituto Nazionale dei Tumori ### 1431483###Co-Author######Fondazione IRCCS Istituto Nazionale dei Tumori###Co-Author: Federica Perrone, MD – Fondazione IRCCS Istituto Nazionale dei Tumori
### @@@ Lukas B. Been, MD, PhD – Department of Surgical Oncology, University Medical Center Groningen, University of Groningen ### 1431479###Co-Author######Department of Surgical Oncology, University Medical Center Groningen, University of Groningen###Co-Author: Lukas B. Been, MD, PhD – Department of Surgical Oncology, University Medical Center Groningen, University of Groningen
### @@@ Robert J. Van Ginkel, MD, PhD – Department of Surgical Oncology, University Medical Center Groningen, University of Groningen ### 1431031###Co-Author######Department of Surgical Oncology, University Medical Center Groningen, University of Groningen###Co-Author: Robert J. Van Ginkel, MD, PhD – Department of Surgical Oncology, University Medical Center Groningen, University of Groningen
### @@@ Marc H.A. Bemelmans, MD, PhD (he/him/his) – Department of Surgery, Maastricht University Medical Center+, Maastricht ### 1431478###Co-Author###Surgical Oncologist###Department of Surgery, Maastricht University Medical Center+, Maastricht###Co-Author: Marc H.A. Bemelmans, MD, PhD (he/him/his) – Department of Surgery, Maastricht University Medical Center+, Maastricht
### he/him/his @@@ Jos A. van der Hage, MD, PhD – Department of Surgery, Leiden University Medical Center ### 1429581###Co-Author###Prof.###Department of Surgery, Leiden University Medical Center###Co-Author: Jos A. van der Hage, MD, PhD – Department of Surgery, Leiden University Medical Center
### @@@ Sander D.S. Dijkstra, MD, PhD – Department of Surgery, Leiden University Medical Center ### 1431477###Co-Author######Department of Surgery, Leiden University Medical Center###Co-Author: Sander D.S. Dijkstra, MD, PhD – Department of Surgery, Leiden University Medical Center
### @@@ Silvia Stacchiotti (she/her/hers) – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy ### 1136386###Co-Author###Medical Oncologist###Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy###Co-Author: Silvia Stacchiotti (she/her/hers) – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
### she/her/hers @@@ Cornelis Verhoef, N/A, MSc, MD, PhD – Erasmus Medical Center ### 1429528###Co-Author###Professor of Surgery###Erasmus Medical Center###Co-Author: Cornelis Verhoef, N/A, MSc, MD, PhD – Erasmus Medical Center
### @@@ Alessandro Gronchi, MD, FSSO (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori ### 1136460###Co-Author###Surgical Oncologist###Fondazione IRCCS Istituto Nazionale dei Tumori###Co-Author: Alessandro Gronchi, MD, FSSO (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori
### he/him/his Paper 77Author: Kyle B. Williams, PhD – Univerysity of Minnesota
### @@@ Alex Larsson, BS – University of Minnesota ### 1430121###Co-Author###Research Scientist###University of Minnesota###Co-Author: Alex Larsson, BS – University of Minnesota
### @@@ Justin Tibbits, MS, MBA – University of Minnesota ### 1430122###Co-Author###Research Scientist###University of Minnesota###Co-Author: Justin Tibbits, MS, MBA – University of Minnesota
### @@@ Tyler Jubenville, MS – University of Minnesota ### 1430124###Co-Author###Research Scientist###University of Minnesota###Co-Author: Tyler Jubenville, MS – University of Minnesota
### @@@ Christopher L. Moertel, MD – University of Minnesota ### 1430123###Co-Author###Professor###University of Minnesota###Co-Author: Christopher L. Moertel, MD – University of Minnesota
### @@@ David A. Largaespada, PhD – University of Minnesota ### 1430125###Co-Author###Professor###University of Minnesota###Co-Author: David A. Largaespada, PhD – University of Minnesota
### Paper 29Author: Katrina M. Ingley, MBChB, FRACP, FRCPA – Sarcoma Department, University College Hospital, London, UK
### @@@ Lauren Birkett, MSc, BNurs (Hons) – Teenage Young Adult AC Unit, University College Hospital MacMillan Centre, London ### 1768798###Co-Author###Advanced Nurse Practitioner###Teenage Young Adult AC Unit, University College Hospital MacMillan Centre, London###Co-Author: Lauren Birkett, MSc, BNurs (Hons) – Teenage Young Adult AC Unit, University College Hospital MacMillan Centre, London
### @@@ Caroline Newton, Dip Nursing, MA (Psychotherapy) – Teenage Young Adult AC Unit, University College Hospital MacMillan Cancer Centre, London ### 1768799###Co-Author###Clinical Nurse Specialist Teenage Cancer###Teenage Young Adult AC Unit, University College Hospital MacMillan Cancer Centre, London###Co-Author: Caroline Newton, Dip Nursing, MA (Psychotherapy) – Teenage Young Adult AC Unit, University College Hospital MacMillan Cancer Centre, London
### @@@ Catherine Farmer, BNurs – Teenage Young Adult AC Unit, University College Hospital MacMillan Cancer Centre, London ### 1768800###Co-Author###Clinical Nurse Specialist Teenage Cancer###Teenage Young Adult AC Unit, University College Hospital MacMillan Cancer Centre, London###Co-Author: Catherine Farmer, BNurs – Teenage Young Adult AC Unit, University College Hospital MacMillan Cancer Centre, London
### @@@ Rachael Windsor, BSc Hons, MBBS Hons, MRCPCH, MSc, MDRes – Sarcoma Department, University College Hospital, London ### 1768801###Co-Author###Consultant Paediatric and Adolescent Oncologist###Sarcoma Department, University College Hospital, London###Co-Author: Rachael Windsor, BSc Hons, MBBS Hons, MRCPCH, MSc, MDRes – Sarcoma Department, University College Hospital, London
### @@@ Maria Michelagnoli, MD – Sarcoma Department, University College London Hospital ### 1768708###Co-Author###Paediatric Oncologist###Sarcoma Department, University College London Hospital###Co-Author: Maria Michelagnoli, MD – Sarcoma Department, University College London Hospital
### @@@ Alison Finch, BNurs – Teenage Young Adult AC Unit, University College Hospital MacMillan Cancer Centre, London ### 1768802###Co-Author###Assistant Chief Nurse###Teenage Young Adult AC Unit, University College Hospital MacMillan Cancer Centre, London###Co-Author: Alison Finch, BNurs – Teenage Young Adult AC Unit, University College Hospital MacMillan Cancer Centre, London
### @@@ Lisa-Marie McMonagle, BNurs – Teenage Young Adult AC Unit, University College Hospital MacMillan Cancer Centre, London ### 1768803###Co-Author###Teenage Cancer Trust Nurse Consultant, UCLH###Teenage Young Adult AC Unit, University College Hospital MacMillan Cancer Centre, London###Co-Author: Lisa-Marie McMonagle, BNurs – Teenage Young Adult AC Unit, University College Hospital MacMillan Cancer Centre, London
### @@@ Sandra J. Strauss, MRCP PhD – Sarcoma Department, University College Hospital, London ### 1430060###Co-Author###Consultant Medical Oncologist###Sarcoma Department, University College Hospital, London###Co-Author: Sandra J. Strauss, MRCP PhD – Sarcoma Department, University College Hospital, London
### Paper 52Author: Patrick Schöffski, MD, MPH – Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute
### @@@ Luna De Sutter, MA (she/her/hers) – Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute ### 1430748###Co-Author###PhD student###Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute###Co-Author: Luna De Sutter, MA (she/her/hers) – Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute
### she/her/hers @@@ Jasper Verreet, N/A, n/a – Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute ### 1768698###Co-Author######Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute###Co-Author: Jasper Verreet, N/A, n/a – Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute
### @@@ Ulla Vanleeuw – Laboratory of Experimental Oncology, Department of Oncology, KU Leuven and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute ### 1430752###Co-Author###Lab technician###Laboratory of Experimental Oncology, Department of Oncology, KU Leuven and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute###Co-Author: Ulla Vanleeuw – Laboratory of Experimental Oncology, Department of Oncology, KU Leuven and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute
### @@@ Lore De Cock, MD – Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute ### 1430749###Co-Author###PhD student###Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute###Co-Author: Lore De Cock, MD – Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute
### @@@ Nina Linde, N/A, MD – The healthcare business of Merck KGaA ### 1768699###Co-Author######The healthcare business of Merck KGaA###Co-Author: Nina Linde, N/A, MD – The healthcare business of Merck KGaA
### @@@ Christine Drechsler, N/A, MD – The healthcare business of Merck KGaA ### 1768700###Co-Author######The healthcare business of Merck KGaA###Co-Author: Christine Drechsler, N/A, MD – The healthcare business of Merck KGaA
### @@@ Christina Esdar, PhD (she/her/hers) – The healthcare business of Merck KGaA ### 1768701###Co-Author###Head Oncogenic Signaling Research###The healthcare business of Merck KGaA###Co-Author: Christina Esdar, PhD (she/her/hers) – The healthcare business of Merck KGaA
### she/her/hers @@@ Raf Sciot, N/A, MD, PhD – Department of Pathology, KU Leuven and University Hospitals Leuven ### 1429885###Co-Author######Department of Pathology, KU Leuven and University Hospitals Leuven###Co-Author: Raf Sciot, N/A, MD, PhD – Department of Pathology, KU Leuven and University Hospitals Leuven
### @@@ Agnieszka Wozniak, PhD, DSc (she/her/hers) – Laboratory of Experimental Oncology, Department of Oncology, KU Leuven and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute ### 1094357###Co-Author###Associate professor###Laboratory of Experimental Oncology, Department of Oncology, KU Leuven and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute###Co-Author: Agnieszka Wozniak, PhD, DSc (she/her/hers) – Laboratory of Experimental Oncology, Department of Oncology, KU Leuven and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute
### she/her/hers Paper 46